News | Breast Density | April 06, 2017

Beginning Oct. 1, 2017, mammography facilities will be required to notify patients if they have dense fibroglandular breast tissue, warn them of increased cancer risk

Colorado, fibroglandular breast density, reporting bill, mammography, breast cancer

April 6, 2017 — Colorado Gov. John Hickenlooper signed the Dense Breast Tissue Reporting Bill (SB17-142) on April 6, adding to the growing list of density reporting laws across the country. The signing makes Colorado the 29th state to enact some form of legislation requiring mammography facilities to notify patients about the impact of fibroglandular breast density on cancer detection and risk.

The language of SB17-142 requires mammography providers to include a notification in the report provided to the patient if the patient is found to have dense fibroglandular breast tissue. The notice must also inform the patient that while common, dense breast tissue can make it more difficult to evaluate the results of the mammogram and it is associated with an increased risk of breast cancer.

The bill was introduced in the Colorado Legislature by Sen. Angela Williams and sponsored in the House by Rep. Jessie Danielson.  The Colorado Breast Density Coalition actively advocated for the law.

“This is a victory for Colorado women,” said Williams.  "Now all women in Colorado will have the same information as their doctors."  

Danielson added, "This law encourages patients to discuss with healthcare providers screening options that are personalized to a patient with dense breast tissue. It is one solution to increase the early detection of breast cancer."

The law is effective on Oct. 1, 2017.  Currently, New Mexico, Iowa and Kentucky have breast density reporting bills awaiting governors' action.

For more information on dense breast tissue, read the article "Mammographic Breast Density — What It Means."

For more information: www.areyoudense.org


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
Subscribe Now